Hepcidin is elevated in primary and secondary myelofibrosis and remains elevated in patients treated with ruxolitinib. (6th February 2022)

Record Type:: Journal Article
Title:: Hepcidin is elevated in primary and secondary myelofibrosis and remains elevated in patients treated with ruxolitinib. (6th February 2022)
Main Title:: Hepcidin is elevated in primary and secondary myelofibrosis and remains elevated in patients treated with ruxolitinib
Authors:: Zhou, Amy
Kong, Tim
Fowles, Jared S.
Jung, Chun‐Ling
Allen, Maggie J.
Fisher, Daniel A. C.
Fulbright, Mary
Nemeth, Elizabeta
Ganz, Tomas
Oh, Stephen T.
Abstract:
Is Part Of:: British journal of haematology. Volume 197:Number 4(2022)
Journal:: British journal of haematology
Issue:: Volume 197:Number 4(2022)
Issue Display:: Volume 197, Issue 4 (2022)
Year:: 2022
Volume:: 197
Issue:: 4
Issue Sort Value:: 2022-0197-0004-0000
Page Start:: e49
Page End:: e52
Publication Date:: 2022-02-06
Subjects:: Hematology -- Periodicals
Blood -- Diseases -- Periodicals
616.15
Journal URLs:: http://www.blacksci.co.uk/%7Ecgilib/jnlpage.bin?Journal=bjh&File=bjh&Page=aims ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2141 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1111/bjh.18044 ↗
Languages:: English
ISSNs:: 0007-1048
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 2309.000000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 27127.xml